MedinCell S.A. Profile Avatar - Palmy Investing

MedinCell S.A.

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceuti…

Biotechnology
FR, Jacou [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of MEDCL.PA's Analysis
CIK: - CUSIP: F6104D107 ISIN: FR0004065605 LEI: - UEI: -
Secondary Listings
MEDCL.PA has no secondary listings inside our databases.